SERUM VISFATIN CONCENTRATION IN PATIENTS WITH METABOLIC SYNDROME

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FOROUGHI M.; HOSSEINZADEH M.J.; ZAHEDIASL S.; HOSEINPANAH F.; MOMENAN A.A.; ESHRAGHIAN M.R.; SABOUR YARAGHI A.A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Endocrinology & Metabolism Year:2009 | Volume:11 | Issue:2 (SN 44) Page(s): 151-157

Download Full-Text

Persian Verion

View:

799

Download:

Cites:

Information Journal Paper

Title

SERUM VISFATIN CONCENTRATION IN PATIENTS WITH METABOLIC SYNDROME

Author(s)

Keywords

VISFATINQ2

METABOLIC SYNDROMEQ2

ADIPOKINEQ3

Abstract

Introduction: Recent studies indicate that VISFATIN, a newly identified adipocytokine, may have potential proinflammatory effects. Since, the relationship between serum VISFATIN levels and METABOLIC SYNDROME (MetS) has not been established, the aim of this study was to explore the association between serum VISFATIN levels and anthropometric variables and the METABOLIC SYNDROME. Materials and Methods: Thirty-seven patients with MetS and 37 age matched controls (mean age 46.35±1.6 years) were included. METABOLIC SYNDROME in patients was defined based on the 2005 criteria of the International Diabetes Federation, and anthropometric and biochemical profiles were documented. Serum VISFATIN was measured using an enzyme immunoassay (EIA) kit. Using the t-test, data were compared between groups and Pearson's correlation coefficient was used to evaluate the relationship between continuous variables. P values <0.05 were considered as statistically significant. Results: Serum VISFATIN level was significantly lower in METABOLIC SYNDROME patients (P<0. 05) compared controls, log VISFATIN: 1.74 ± 0.27ng/ml vs. 1.86 ±0.13 ng/ml, respectively. There was no significant correlation between serum VISFATIN levels and any anthropometric or any metabolic parameters in patients with METABOLIC SYNDROME or the control group. Conclusions: The results of this study showed that serum VISFATIN level was decreased in patients with MetS, indicating that VISFATIN cannot be considered as a new proinflammatory adipocytokine for the METABOLIC SYNDROME.

Cites

References

No record.

Cite

APA: Copy

FOROUGHI, M., HOSSEINZADEH, M.J., ZAHEDIASL, S., HOSEINPANAH, F., MOMENAN, A.A., ESHRAGHIAN, M.R., & SABOUR YARAGHI, A.A.. (2009). SERUM VISFATIN CONCENTRATION IN PATIENTS WITH METABOLIC SYNDROME. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 11(2 (SN 44)), 151-157. SID. https://sid.ir/paper/27383/en

Vancouver: Copy

FOROUGHI M., HOSSEINZADEH M.J., ZAHEDIASL S., HOSEINPANAH F., MOMENAN A.A., ESHRAGHIAN M.R., SABOUR YARAGHI A.A.. SERUM VISFATIN CONCENTRATION IN PATIENTS WITH METABOLIC SYNDROME. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2009;11(2 (SN 44)):151-157. Available from: https://sid.ir/paper/27383/en

IEEE: Copy

M. FOROUGHI, M.J. HOSSEINZADEH, S. ZAHEDIASL, F. HOSEINPANAH, A.A. MOMENAN, M.R. ESHRAGHIAN, and A.A. SABOUR YARAGHI, “SERUM VISFATIN CONCENTRATION IN PATIENTS WITH METABOLIC SYNDROME,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 11, no. 2 (SN 44), pp. 151–157, 2009, [Online]. Available: https://sid.ir/paper/27383/en

Related Journal Papers